✦ LIBER ✦

Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis

✍ Scribed by Fontana, Robert J; Everson, Gregory T; Tuteja, Sony; Vargas, Hugo E; Shiffman, Mitchell L

Book ID: 122470538
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 214 KB
Volume: 2
Category: Article
ISSN: 1542-3565
DOI: 10.1016/S1542-3565(04)00002-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[518] EFFICACY OF ENTECAVIR AND LAMIVUDI

[518] EFFICACY OF ENTECAVIR AND LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS

✍ H. Simsek; E. Schiff; Z. Goodman; H. Brett-Smith; K. Klesczewski; B. Kreter 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Regression of hepatic fibrosis and cirrh

Regression of hepatic fibrosis and cirrhosis in patients with chronic hepatitis C treated with interferon-based therapy

✍ Mohammed A Metwally; Claudia O Zein; Nizar N Zein 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Hepatocellular Carcinoma in Chronic Hepa

Hepatocellular Carcinoma in Chronic Hepatitis C in the Absence of Advanced Fibrosis or Cirrhosis

✍ Lewis, Sara; Roayaie, Sasan; Ward, Stephen C.; Shyknevsky, Inna; Jibara, Ghalib; 📂 Article 📅 2013 🏛 American Roentgen Ray Society 🌐 English ⚖ 994 KB

Noninvasive Diagnosis of Liver Fibrosis

Noninvasive Diagnosis of Liver Fibrosis and Cirrhosis in Chronic Hepatitis C Patients

✍ Attallah, Abdelfattah M.; El-Far, Mohamed; Omran, Mohamed M.; Farid, Khaled; Alb 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Hepatic Akt expression correlates with a

Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection

✍ Jee-Fu Huang; Yen-Hwang Chuang; Chia-Yen Dai; Ming-Lung Yu; Chung-Feng Huang; Pi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis